Resonant Expands Biorepository Network With Creapharm Deal
Bailly-Romainvilliers, France — September 3, 2026 Resonant Clinical Solutions announced the acquisition of Creapharm Bioservices from Myonex, strengthening its...
GMP
Advertisement
4basebio and Genezen Expand Synthetic DNA Collaboration
CAMBRIDGE, UK and INDIANAPOLIS, IN — August 26, 2026 4basebio PLC and Genezen announced an expanded, non-exclusive strategic collaboration...
Hyperfine Gains FDA Clearance for Next Optive AI Software
Guilford, Connecticut, August 20, 2026 Hyperfine announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s...
Charles River and Medigen Advance Vaccine Development With NGS
Wilmington, Massachusetts, August 20, 2026 Charles River Laboratories International and Medigen Vaccine Biologics Corp. (MVC) have entered into a...
Genprex Advances Diabetes Gene Therapy Manufacturing Scale-Up
AUSTIN, Texas, August 18, 2026 Genprex, Inc. has entered into a development and manufacturing agreement with a leading U.S.-based...
Advertisements
WuXi Biologics MFG8 Secures FDA PLI for Autoimmune Therapy
HEBEI, China | July 9, 2026 WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has...
Nucleus Biologics Launches CRAIC Formulation Finder
SAN DIEGO, Calif., July 7, 2026 Nucleus Biologics has launched CRAIC™ Formulation Finder, a new large language model (LLM)-powered...
RoosterBio and Applied StemCell Partner to Scale iPSC Manufacturing
MILPITAS, Calif. & FREDERICK, Md., July 8, 2026 RoosterBio and Applied StemCell (ASC) have announced a strategic partnership to...
Vector Secures Exclusive cGMP Peptide Manufacturing Deal
MEQUON, Wis., July 7, 2026 Vector Science & Therapeutics Corp. has entered into a landmark exclusive licensing and cGMP...
Olympus Gains FDA Clearance for POWERSEAL Open Device
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEAL™ Open...
Advertisement
